Ranibizumab Patent Expiration
Ranibizumab Large Molecule Patents
Given below is the list of large molecule patents protecting Ranibizumab, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lucentis | USUS10112994 | Methods of producing two chain proteins in bacteria | Nov 05, 2035 | Genentech, Inc. |
| Lucentis | USUS10421984 | Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele | Sep 19, 2033 | Genentech, Inc. |
| Lucentis | USUS6716602 | Metabolic rate shifts in fermentations expressing recombinant proteins |
Nov 01, 2021
(Expired) | Genentech, Inc. |
| Lucentis | USUS6828121 | Bacterial host strains |
Jul 08, 2022
(Expired) | Genentech, Inc. |
| Lucentis | USUS6921659 | Protease-deficient cells |
Oct 17, 2023
(Expired) | Genentech, Inc. |
| Lucentis | USUS8383773 | Protein product and method for reducing biomass-biomass interactions |
Dec 13, 2023
(Expired) | Genentech, Inc. |
| Lucentis | USUS9688775 | System for antibody expression and assembly |
Dec 31, 2022
(Expired) | Genentech, Inc. |
| Lucentis | USUS9765379 | Harvest operations for recombinant proteins | Mar 10, 2034 | Genentech, Inc. |
Ranibizumab's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List